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Review
It is well recognized that the fetus and infant 
are especially vulnerable to the effects of envi-
ronmental risk factors that disrupt develop-
mental processes, due to a) critical windows 
of vulnerability that occur during the rapid 
growth and development of organs and 
systems, b) immaturities in metabolism, and 
c) greater intake and absorption of noxious 
agents in children relative to their body weight 
(Grandjean et al. 2008). Chemical, physical, 
and biological hazards in the environment may 
lead to serious health problems at birth and 
during childhood, ranging from premature 
birth, low birth weight, and congenital anoma-
lies to respiratory diseases, childhood cancer, 
learning disabilities, behavioral problems, and 
possibly even obesity (Trasande et al. 2009; 
Wigle et al. 2007). The economic and societal 
costs associated with nonoptimal child health 
and development are substantial. Furthermore, 
the effects of exposure to environmental risk 
factors may manifest themselves throughout a 
lifetime and even over generations. Common 
physical and mental diseases in adult life 
appear to have part of their origin in early life 
(Gillman et al. 2007; Kuh et al. 2003).
Epidemiological studies worldwide have 
investigated the role of early environmental 
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Ba c k g r o u n d: Many pregnancy and birth cohort studies investigate the health effects of early-life 
  environmental contaminant exposure. An overview of existing studies and their data is needed to 
improve collaboration, harmonization, and future project planning.
oBjectives: Our goal was to create a comprehensive overview of European birth cohorts with envi-
ronmental exposure data.
Me t h o d s : Birth cohort studies were included if they a) collected data on at least one environmen-
tal exposure, b) started enrollment during pregnancy or at birth, c) included at least one follow-up 
point after birth, d) included at least 200 mother–child pairs, and e) were based in a European 
country. A questionnaire collected information on basic protocol details and exposure and health 
outcome assessments, including specific contaminants, methods and samples, timing, and number 
of subjects. A full inventory can be searched on www.birthcohortsenrieco.net.
re s u l t s: Questionnaires were completed by 37 cohort studies of > 350,000 mother–child pairs 
in 19 European countries. Only three cohorts did not participate. All cohorts collected biological 
specimens of children or parents. Many cohorts collected information on passive smoking (n = 36), 
maternal occupation (n = 33), outdoor air pollution (n = 27), and allergens/biological organisms 
(n = 27). Fewer cohorts (n = 12–19) collected information on water contamination, ionizing or 
nonionizing radiation exposures, noise, metals, persistent organic pollutants, or other pollutants. All 
cohorts have information on birth outcomes; nearly all on asthma, allergies, childhood growth and 
obesity; and 26 collected information on child neurodevelopment.
co n c l u s i o n: Combining forces in this field will yield more efficient and conclusive studies and 
ultimately improve causal inference. This impressive resource of existing birth cohort data could form 
the basis for longer-term and worldwide coordination of research on environment and child health.
key w o r d s : birth cohorts, child health, environmental exposures, Europe, review. Environ Health 
Perspect 120:29–37 (2012).  http://dx.doi.org/10.1289/ehp.1103823 [Online 29 August 2011]Vrijheid et al.
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contaminant exposures on pregnancy outcomes 
and child health (Wigle et al. 2007). Many 
have suffered from biases due to retrospective 
study designs, surrogate exposure and outcome 
measures, and incomplete confounder data. 
Pregnancy and birth cohort studies are ide-
ally suited to improve causal inference in this 
field, because they are designed to study the 
impacts of early exposures prospectively and 
at multiple time points during development 
of the child. Furthermore, birth cohort studies 
usually collect biological material from moth-
ers and children, enabling the measurement of 
biomarkers of exposure, early effect, or suscep-
tibility. In the last two decades, new pregnancy 
Table 1. General description of European birth cohorts with environmental contaminant data.
Birth cohort Full name and key reference Country Regions covered
Enrollment 
period
No.  
of children   
at birth
Eligible cohorts that completed the ENRIECO inventory questionnaires:
ABCD Amsterdam Born Children and their Development study (van Eijsden 
et al. 2010)
Netherlands Amsterdam 2003–2004 7,863
ALSPAC The Avon Longitudinal Study of Parents and Children (Golding et al. 2001) United Kingdom Bristol 1991–1992 14,062
ArcRisk-Norway Impacts on health in the Arctic and Europe owing to climate-induced 
changes in contaminant cycling
Norway Troms, Finnmark, and Nordland 2007–2009 430
BAMSE The Stockholm Children Allergy and Environmental Prospective Birth 
Cohort Study (Wickman et al. 2002)
Sweden Stockholm 1994–1996 4,089
BiB Born in Bradford (Raynor 2008) United Kingdom Bradford 2007–2010 13,000
Co.N.ER Cohort of newborns in Emilia Romagna (Porta et al. 2006) Italy Bologna 2004–2005 654
Czech Czech Republic Early Childhood Health (Dejmek et al. 2000) Czech Republic Teplice and Prachatice 1994–1999 7,577
DARC The Danish Allergy Research Centre cohort (Johnke et al. 2005) Denmark Odense 1998–1999 562
DNBC Danish National Birth Cohort (Olsen et al. 2001) Denmark Denmark 1996–2002 96,986
Duisburg Duisburg cohort (Wilhelm et al. 2008) Germany Duisburg 2000–2003 234
EDEN Study of determinants of pre and postnatal developmental, psychomotor 
development and child health (Drouillet et al. 2009)
France Nancy, Poitiers 2003–2006 1,899
ELFE French longitudinal study of children (Vandentorren et al. 2009) France France 2011–2012 20,000
Faroesa Children’s Health and the Environment in the Faroes (Grandjean et al. 
1992, 1997)
Faroe Islands Faroe Islands 1986–2009 2,351
FLEHS I Flemish Environment and Health Survey (Koppen et al. 2009) Belgium Flanders 2002–2004 1,196
GASPII Gene and Environment: Prospective Study on Infancy in Italy (Porta et al. 
2007)
Italy Rome 2003–2004 708
Generation R Generation R (Jaddoe et al. 2008) Netherlands Rotterdam 2001–2006 9,778
Generation XXI Generation XXI (Pinto et al. 2009) Portugal Porto 2005–2006 8,647
GINIplus German Infant Nutritional Intervention Study – plus influence of pollution 
and genetics on allergy development (Zirngibl et al. 2002)
Germany Munich, Wesel 1995–1998 5,991
HUMIS Norwegian Human Milk Study (Eggesbo et al. 2009) Norway Norway 2002–2011 2,500
INMA oldb Environment and Childhood (Guxens et al. 2011) Spain Granada, Menorca, Ribera d’Ebre 1997–2002 1,252
INMA newc Environment and Childhood (Guxens et al. 2011) Spain Asturias, Gipuzkoa, Sabadell, Valencia 2003–2008 2,505
INUENDOd Biopersistent organochlorines in diet and human fertility (Toft et al. 2005) Greenland, Sweden, 
Poland, Ukraine
Greenland, Sweden (east and west coast), 
Warsaw (Poland), Kharkiv (Ukraine)
2002–2004 1,322
KANC Kaunas cohort (Grazuleviciene et al. 2009) Lithuania Kaunas 2007–2009 4,000
KOALA Child, parents and health: lifestyle and genetic constitution (Kummeling 
et al. 2005)
Netherlands Southern Netherlands 2000–2003 2,834
Kraków Kraków cohort (Jedrychowski et al. 2003) Poland Kraków 2000–2003 505
Leicestere The Leicester Respiratory Cohorts (Kuehni et al. 2007) United Kingdom Leicestershire and Rutland 1985–1997 10,350
LISAplus Influences of life-style related factors on the immune system and the 
development of allergies in childhood – plus the influence of traffic 
emissions and genetic (Heinrich et al. 2002)
Germany Munich, Wesel, Leipzig, Bad Honneff 1997–1998 3,097
LUKAS LUKAS (Karvonen et al. 2009) Finland Kuopio, Jyväskylä, Joensuu, and Iisalmi 2002–2005 442
MAS Multicentre Allergy Study (Bergmann et al. 1994) Germany Berlin, Duesseldorf, Freiburg, Mainz, Munich 1990 1,314
MoBa The Norwegian Mother and Child Cohort Study (Magnus et al. 2006) Norway Norway 1999–2008 107,000
NINFEA Birth and Infancy: Effects of the Environment (Richiardi et al. 2007) Italy Italy 2005– 7,500
PARIS Pollution and Asthma Risk: An Infant Study (Clarisse et al. 2007) France Paris 2003–2006 3,840
PCB cohort Early Childhood Development and PCB exposures in Slovakia (Sonneborn 
et al. 2008)
Slovakia Michalovce, Stropkov, Svidnik 2001–2003 1,134
PÉLAGIE Endocrine disruptors: longitudinal study on pregnancy abnormalities, 
infertility, and childhood (Chevrier et al. 2011)
France Brittany 2002–2006 3,421
PIAMA Prevention and Incidence of Asthma and Mite Allergy (Brunekreef et al. 
2002)
Netherlands Northern, western and central parts 1996–1997 3,963
REPRO_PL Polish Mother and Child Cohort (Polanska et al. 2009) Poland Lodz, Wroclaw, Lask, Kielce, Katowice, 
Legnica, Lublin, Szczecin, Piekary Slaskie
2007–2011 1,800
RHEA Mother Child Cohort in Crete (Vardavas et al. 2010) Greece Heraklion, Crete 2007–2008 1,500
Potentially eligible cohorts that did not complete the ENRIECO inventory questionnaire:
Ukraine Children of Ukraine (Hryhorczuk et al. 2009) Ukraine Kyiv, Dniprodzerzhynsk, Mariupol 1992–1996 4,510
MAAS The National Asthma Campaign Manchester Asthma and Allergy Study 
(Custovic et al. 2002)
United Kingdom Manchester 1995–1997 1,211
Northern Adriatic 
Cohort
Northern Adriatic Cohort (Barbone et al. 2004) Italy Northeastern Italy 1999–2001 243
aThe Faroes cohorts consist of four subcohorts: cohort 1 (enrollment: 1986–1987; n = 1022), cohort 2 (enrollment: 1994–1995; n = 182), cohort 3 (enrollment: 1997–2000, n = 656), cohort 5 
(enrollment: 2007–2009; n = 491); bINMA old consists of three subcohorts: Granada (enrollment: 2000–2002; n = 668), Menorca (enrollment: 1997–1998; n = 482), Ribera Ebre (enrollment: 
1997–1999; n = 102); cINMA new consists of four subcohorts: Asturias (enrollment: 2004–2007; n = 485), Gipuzkoa (enrollment: 2006–2008; n = 611), Sabadell (enrollment: 2004–2007; n = 
622), Valencia (enrollment: 2003–2005; n = 787); dINUENDO consists of four subcohorts: Greenland, Sweden (east and west coast), Warsaw (Poland), Kharkiv (Ukraine); eThe Leicester 
Respiratory Cohorts consist of two subcohorts: the Leicester I cohort (enrollment: 1985–1989; n = 1,650) and the Leicester II cohorts (enrollment: 1993–1997; n = 8,700).European birth cohorts
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and birth cohorts have been set up across 
Europe (e.g., Golding et al. 2001; Hofman 
et al. 2004; Magnus et al. 2006; Olsen et al. 
2001; Raynor 2008; Richiardi et al. 2007), in 
North America, and elsewhere (Brown et al. 
2007; Herbstman et al. 2010; Marks et al. 
2010; Richter et al. 2011), and more are being 
planned (Hirschfeld et al. 2011). Many cohort 
studies include assessments of environmen-
tal pollutant exposure, but not all have large 
expertise in this area. Although it is clear that 
individual cohorts are able to make, and have 
made, important contributions to understand-
ing environmental causes of childhood dis-
ease and ill health, it is becoming increasingly 
clear that their full potential can be realized 
only with collaboration across large regions 
(Kogevinas et al. 2004).
The European Union (EU) has funded 
the Environmental Health Risks in European 
Birth Cohorts (ENRIECO) project to coor-
dinate birth cohort research in Europe in the 
area of environmental contaminant expo-
sures (ENRIECO 2009). ENRIECO recog-
nized that a comprehensive overview of birth 
cohorts and their data was needed as a first 
step toward improved collaboration, future 
project planning, and effective use of existing 
data. Currently, no inventory of environmen-
tal exposure data exists. The aim of this review 
is to provide an overview of European birth 
cohorts with data on environmental contami-
nant exposures and health outcomes.
Methods
Definition and identification of cohorts. Birth 
cohort studies were included in the project if 
they a) collected data on at least one environ-
mental contaminant exposure topic (air pollu-
tion, water contamination, pesticides, metals, 
persistent organic pollutants, other chemical 
pollutants, noise, radiations, and allergens and 
biological organisms); b) started enrollment of 
mothers into the cohort during pregnancy or 
at birth; c) included in their protocol at least 
one follow-up point after birth with direct con-
tact with mothers and children; d) included at 
least 200 mother–child pairs (a low sample size 
limit was chosen so small studies with relevant 
exposure data or based in less well-covered 
regions were not excluded); and e) were based 
in a European country. Collection of data on 
an environmental exposure topic included data 
collected through questionnaires, environmen-
tal sampling, spatial maps and models, per-
sonal monitoring, biomarker measurements, 
or a combination of these methods. The mere 
availability of residential location (addresses 
and geocodes) was not sufficient for inclusion. 
All cohorts fitting the criteria were considered 
regardless of when they started, when they con-
ducted their most recent follow-up, whether 
data had been published, or whether recruit-
ment of subjects was ongoing.
Cohorts were identified through a variety of 
sources: www.birthcohorts.net (Birthcohorts.net 
2010), a searchable Web site that contains basic 
protocol information for a number of birth 
cohorts; European projects using birth cohort 
data; and personal contacts. Publications and 
Web sites of identified cohorts were checked to 
see whether the cohort appeared to match the 
criteria of the inventory. All cohorts identified 
as potentially eligible between 1 March 2009 
(start of the project) and 31 December 2010 
were approached.
Inventory questionnaire. An inventory 
questionnaire was designed to collect detailed 
information from the cohorts on biological 
sample collection, assessment of environmental 
exposures, assessment of child health outcomes 
of interest, and basic information on collection 
of other variables. The full questionnaire can 
be found in Supplemental Material, Annex 1 
(http://dx.doi.org/10.1289/ehp.1103823). The 
questionnaire was divided into four sections: 
Basic protocol description: protocol descrip- •	
tion, basic data, and biological sample col-
lection scheme.
Exposure assessment: air pollution (outdoor  •	
and indoor), water contamination, allergens 
and biological organisms, metals, pesticides, 
radiations (ionizing, ultraviolet, and non-
ionizing), tobacco smoke (active and pas-
sive), noise, persistent organic pollutants, 
occupation (maternal and paternal), and 
other chemical compounds. Each section 
asked for the exposure assessment methods 
used, numbers of subjects assessed, and time 
point of assessment.
Health outcome assessment: reproduction  •	
and birth outcomes, neurodevelopment, aller-
gies and asthma, cancer, child growth, and 
metabolic syndrome indicators such as blood 
pressure, cholesterol, triglycerides, insulin, or 
glucose. Each section asked which outcomes 
were assessed, by which methods (if relevant), 
how many subjects were assessed, and the 
time point of assessment.
Other information: mainly yes/no questions  •	
on collection of genotype data, residential 
history, time–activity patterns, sociodemo-
graphic variables, breast-feeding, diet, physical 
exercise, medical history, and anthropometry.
The questionnaire was sent to principal 
investigators of each identified cohort, who 
were asked to distribute specific sections to 
the appropriate researchers and data managers 
within their cohort. The completed question-
naire was checked and, if necessary, the cohort 
study teams were contacted again to correct 
errors and complete information. Cohorts that 
did not reply to the first e-mail were reminded 
repeatedly by e-mail or phone. Cohorts were 
invited to two workshops during the project, in 
which the aims and objectives were presented.
Figure 1. European birth cohort studies collaborating in ENRIECO. 
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A Microsoft Access database was constructed 
to contain the responses from the cohorts. All 
cohorts were asked to check this database for 
errors before making it public. The last correc-
tions and updates were made in February 2011. 
A Web-based searchable inventory is now pub-
licly available on www.birthcohortsenrieco.net 
(ENRIECO 2011) and also accessible through 
www.birthcohorts.net (Birthcohorts.net 2010).
Results
A total of 46 birth cohort studies were iden-
tified as potentially eligible based on publi-
cations, Web sites, and word of mouth. Six 
of these were excluded after completion of 
questionnaires, because they did not match the 
eligibility criteria: Three did not assess envi-
ronmental exposures, and three did not have 
a follow-up point after birth. Another three 
birth cohorts did not return the questionnaires 
(Table 1). The 37 included cohorts, totaling 
> 350,000 study subjects, are situated in 19 
European countries, principally in Northern 
and Western Europe (Figure 1). Five of the 
cohorts are in Eastern Europe and seven in 
Southern Europe (based on the European 
regions classified in the United Nations 
geoscheme). Twenty-five of the 37 cohorts 
defined themselves as regionally based stud-
ies, six as nationally based, four as hospital 
based, and two as studying selected popula-
tions [farmers in the LUKAS cohort and high-
risk allergic children in the Multicentre Allergy 
Study (MAS)]. Two studies, the Danish 
National Birth Cohort (DNBC) and the 
Norwegian Mother and Child Study (MoBa) 
have recruited around 100,000 mother–
child pairs each (Table 1). Ten cohorts have 
recruited between 5,000 and 20,000 pairs, 
18 between 1,000 and 5,000 pairs, and seven 
cohorts   concern < 1,000 pairs.
At our reference date (February 2011), 
children in 19 cohorts were between 5 and 
10 years of age, children in 12 cohorts were 
> 10 years of age, and in five cohorts they were 
< 5 years of age. One cohort in France, Etude 
Longitudinale Française depuis l’Enfance 
(ELFE), started data collection in April 
2011. Most of the cohorts started recruit-
ment of mothers during pregnancy (n = 25); 
the remaining started at birth. Most cohorts 
have multiple follow-up points after birth, 
and the majority have follow-up points in 
each of the child age periods specified in the 
questionnaire (1–6 months, 6–18 months, 
18 months–5 years, 5–10 years, > 10 years) 
(Figure 2).
Biological samples were collected in all 
cohorts from the mother and/or the child and, 
more rarely, from the father (Table 2). Sampling 
covered prenatal and postnatal periods and 
many types of tissue, including blood, urine, 
hair, nails, breast milk, placentas, and saliva. 
All but six cohorts [The Stockholm Children 
Allergy and Environmental Prospective Birth 
Cohort Study (BAMSE); German Infant 
Nutritional Intervention Study—plus influence 
of pollution and genetics on allergy develop-
ment (GINIplus); The Leicester Respiratory 
Cohorts (Leicester); Birth and Infancy: Effects 
of the Environment (NINFEA); Pollution 
and Asthma Risk: An Infant Study (PARIS); 
Prevention and Incidence of Asthma and Mite 
Allergy (PIAMA)] collected, or plan to collect, 
blood samples from the mother during preg-
nancy or cord blood at birth.
Many cohort studies collected informa-
tion on passive smoking (n = 36), maternal 
occupation (n = 33), outdoor air pollution 
(n = 27), and allergens/biological organisms 
(n = 27) (Table 3). Fewer cohorts have col-
lected information on water contamination 
(n = 13), ionizing or nonionizing radiation 
exposures (n = 12), noise (n = 14), or emerg-
ing chemical exposures such as phthalates 
and bisphenol A (n = 17). Details of each 
assessment (methods, numbers of subjects, 
and time period of assessment) can be found 
in the Web inventory (ENRIECO 2011). 
Twenty-seven cohorts have measured or are 
measuring contaminants or their metabolites 
as markers of internal dose, mostly in the cat-
egories of metals, persistent organic pollut-
ants, and tobacco smoke (Table 4).
Figure 2. Start of enrollment and time points of follow-upa (vertical bars) in European birth cohorts collabo-
rating in ENRIECO. T1, T2, and T3 are first, second, and third trimesters. mo, months. See Table 1 for full 
names and locations of cohorts.
aThese are points in predefined periods. Some cohorts have many more (e.g., yearly) follow-points not reflected in this figure. 
The four Faroes cohorts and the two Leicester cohorts are shown separately because they have different time lines.
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All cohorts have information on birth 
outcomes, mostly birth weight, gestational 
age, and mode of delivery [see Supplemental 
Material, Annex 2 (http://dx.doi.org/10.1289/
ehp.1103823)]. Fewer asked questions about 
time to pregnancy or collected data on con-
genital anomalies. Fifteen cohorts collected 
information on ultrasound measurements. 
Neurodevelopment and behavioral devel-
opment of the children was assessed in 26 
cohorts, using a large variety of methods 
including questionnaires, neuropsychologi-
cal tests, and school results. Nineteen cohorts 
assessed cognitive function of the children 
(e.g., global IQ, executive function, memory, 
etc.), 18 cohorts assessed behavior or ADHD 
(attention deficit/hyperactivity disorder) 
symptoms, and few have data on the clinical 
diagnosis of autism (n = 13) or mental health 
problems (n = 3). Names of the questionnaires 
and tests used to assess neurodevelopment, as 
well as the developmental periods at which 
they were used are available in the Web inven-
tory. Growth and obesity and allergies (n = 
34), and asthma and respiratory infections 
(n = 33) were assessed in nearly all cohorts. 
Metabolic syndrome indicators, such as blood 
pressure or cholesterol levels, were collected 
in around half of the cohorts. Childhood 
cancer (n = 12) and sexual maturation (n = 
14) have been assessed in few cohorts to date 
[see Supplemental Material, Annex 2 (http://
dx.doi.org/10.1289/ehp.1103823)].
Discussion
More than 35 birth cohorts in Europe, study-
ing more than 350,000 mother–child pairs, 
have data that can be used to examine associa-
tions between chemical, physical, and biologi-
cal environmental exposures and child health. 
The searchable Web-based inventory is the first 
place where this information is made publicly 
available. The inventory intends to facilitate 
collaborations between birth cohort researchers 
in this field and can be searched to identify 
cohorts relevant for comparison, replication, 
and combined studies. Moreover, it may be 
used by policy makers and other stakeholders 
to identify birth cohorts that can provide spe-
cific information on environmental exposures 
or related outcomes. This initiative may quite 
easily be expanded beyond Europe to stimulate 
collaboration between cohorts worldwide.
The cohorts we evaluated include a few 
very large general cohorts with multiple aims 
as well as many smaller cohorts, which are 
generally more focused on specific environ-
mental risk factors or specific health out-
comes. The distribution of the identified birth 
cohorts is not homogeneous across Europe, 
with more and larger cohorts mostly located 
in the north and west of Europe and fewer 
and smaller cohorts in the south and east. 
Indeed, more than half of all mother–child 
pairs come from two very large cohorts in 
Norway and Denmark. However, studies of 
Table 2. Biological samples collected in the European birth cohorts collaborating in ENRIECO.a
Mother
Child
Father
Birth
1–6 
months
7–18 
months 19 months–5 years
5–10 
years
≥ 10 
years Cohort T1 T2 T3 Birth Postnatal Prenatal Postnatal
ABCD B B
ALSPAC B, U B, U B, U P H, N CB H, N B, H, N B, U, T B, U, S H, N
ArcRisk-Norway B, U B, U, H B, U, BM CB, B, M
BAMSE B, U B
BiB B, U CB B B S
Co.N.ER B CB
Czech B, P CB U U
DARC CB B B B B
DNBC B B CB B
Duisburg B B, U, BM CB B, U B, U
EDEN B, U, S H, BM, P CB, H, M H H B, U, H B
ELFE B, U, BM, H CB, CT, M U, H, S U
Faroes B H, BM B, U, H, BM CB B B, H B, H B, H B, H U, H, Se
FLEHS I S CB F F U U
GASPII B CB
Generation R B, U B, U B, U CB S B, U, S B
Generation XXI B B B, AT B CB B B
GINIplus B B B
HUMISb B, U B BM CB S B
INMA old B B B B, BM, P B, BM CB, U B B B, U, H, S B, U B
INMA new B, U U, N BM, P U, S CB, H U, N, S H, S B, U, H, S B, S
INUENDO B B B S B, Se
KANC B B
KOALA B BM, S F S B B, F S
Kraków B, P U CB, M U B, U U
Leicester S
LISAplus CB, B B B B
LUKAS B, P BM CB F B, F B B, U B
MAS B CB, B B, U B, U B, U B B
MoBa B, U B CB B
NINFEA S S
PARIS B B, U
PCB cohort B, BM CB B B B B, U
PELAGIE U H, P CB S, U
PIAMA B, BM, S B B B, S B B, S B, S
REPRO_PL B, S B, U, S B, U, H, S B BM CB B, U B, U
RHEA B, U U B CB U, H B B, Se
Abbreviations: AT, adipose tissue; B, blood; BM, breast milk; CB, cord blood; CT, cord tissue; F, feces; H, hair; M, meconium; N, nails; P, placenta; S, saliva or buccal swabs; Se, semen; 
T, teeth; U, urine. T1, T2, and T3 are first, second, and third trimesters. See Table 1 for full names and locations of cohorts.
aMany but not all ENRIECO birth cohorts are also included in the BBMRI Catalogue of European Biobanks (BBMRI 2011), which can be queried by specimen type. bBlood, urine, and 
cord blood are available through overlap with MoBa in approximately 800 participants.Vrijheid et al.
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environmental contaminant exposures, espe-
cially those measuring exposure biomark-
ers, usually cannot cover large numbers of 
subjects. Smaller, specialized cohorts, often 
located in high-exposure areas, have made 
very important contributions in this regard.
Passive smoking, maternal (and paternal, 
less often) occupation, air pollution, and aller-
gen exposures have been assessed by many 
birth cohorts. Efforts to combine data analyses 
on these topics are already ongoing within 
international projects such as European Study 
of Cohorts for Air Pollution Effects (ESCAPE) 
(2009), Global Allergy and Asthma European 
Network (GA2LEN) (2009), and International 
Collaboration on Air Pollution and Pregnancy 
Outcomes (ICAPPO) (Woodruff et al. 2010). 
Biomarker data on some metals (lead and 
mercury) and some persistent organic pollut-
ants [polychlorinated biphenyls (PCBs) and 
dichlorodiphenyldichloroethylene (DDE)] are 
also available in a relatively large number of 
cohorts, but usually for a small number of sub-
jects in each cohort and with considerable vari-
ation in the type and timing of the biological 
samples. Studies combining data from differ-
ent cohorts have been conducted for few such 
pollutants so far; examples are the 7-cohort 
lead meta-analysis (Lanphear et al. 2005) and 
a recent meta-analysis of 12 European cohorts 
evaluating PCB and DDE exposure and fetal 
growth (Govarts et al. 2011). Exposure areas 
that are less well covered in the cohorts include 
noise, ionizing and nonionizing radiations, 
and chemical exposures such as brominated 
and fluorinated compounds, phthalates, and 
phenols (including bisphenol A). These are 
areas of emerging concern for child health 
and high on international research agendas 
[e.g., the World Health Organization (WHO) 
Research Agenda for Radiofrequency Fields] 
(WHO 2010). Although actual measurements 
are scarce, future assessments of these expo-
sures are planned in many cohorts, making 
this an optimal time to work toward a high 
level of data comparability.
Birth cohorts are most suitable to examine 
child health outcomes that are common or 
can be measured on a continuous scale. Rare 
outcomes and pathologies such as extremely 
preterm birth, childhood cancers, congeni-
tal anomalies, and autism can be studied 
only in the very large cohorts or by combin-
ing cohorts, as is being done, for example, in 
the International Childhood Cancer Cohort 
Consortium (Brown et al. 2007). All cohorts 
collected information on fetal growth and 
gestational length and on childhood anthro-
pometric measures; combined studies of 
these outcomes appear feasible. A number of 
cohorts specialize in the early causes of asthma 
and allergies, and combined studies of these 
outcomes are underway (Keil et al. 2006a, 
2006b). Neurodevelopment is a wide area that 
encompasses many cognitive and behavioral 
outcomes and includes even more assessment 
Table 3. Assessment of environmental exposures (prenatal or postnatal) in European birth cohorts participating in ENRIECO.a 
Cohort
Air 
pollution 
outdoor
Air 
pollution 
indoor
Water 
contamination
Allergens and 
biological 
organisms Metalsb Pesticidesc
Persistent 
organic 
pollutants
Other 
chemical 
exposuresd Radiations
Passive 
smokinge Noise Occupation
ABCD X X Xg X X
ALSPAC X X X X Xg X X X X
ArcRisk-Norway X X Xg X X
BAMSE X X X X X
BiB X X X
Co.N.ER Xg X X X X X
Czech X X X
DARC X X X X X
DNBC Xg X X X X X X X
Duisburg X X Xg X X X X X X
EDEN X X Xg X X X X X
ELFE Xg Xg Xg Xg Xg Xg Xg Xg Xg Xg Xg
Faroes X Xg X Xg X X
FLEHS I X X X X X X X X
GASPII X X X X X
Generation R X X X Xg X X X X
Generation XXI X X X
GINIplus X X X X
HUMISf X X X X Xg X X X X X X
INMA old X X X X Xg X X X X X X X
INMA new X X X X X X X X X X X X
INUENDO Xg Xg Xg Xg X X
KANC X X X Xg X
KOALA X X X Xg X X X
Kraków X X X X X X X X X
Leicester X X X X X
LISAplus X X X X Xg
LUKAS X X X X X Xg X X
MAS X X X X X
MoBa Xg X X X Xg X Xg X X X X X
NINFEA Xg Xg Xg Xg Xg Xg Xg Xg Xg
PARIS X X X X X X
PCB cohort X X X X Xg X X
PELAGIE X X X X X X X X
PIAMA X X X X
REPRO_PL Xg X X X X X X
RHEA X X X X X X Xg Xg X X X X
See Table 1 for full names and locations of cohorts.
aDetails of each assessment (method, time period, number of subjects) are available at www.birthcohortsenrieco.net (ENRIECO 2011). bBiomonitoring data only, not questionnaires. 
cOrganochlorine pesticides are included under persistent organic pollutants. dPhthalates and phenols (including bisphenol A). ePassive smoking exposure of the mother during preg-
nancy or of the child postnatally. fData on occupation and passive smoking are available through overlap with MoBa in approximately 800 participants. gMeasurements are planned or 
ongoing but not completed.European birth cohorts
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instruments, ranging from parental question-
naires on developmental milestones to detailed 
neuropsychological assessments. Combined 
analyses may therefore prove difficult and may 
need to be restricted to cohorts that use similar 
tests in similar age groups.
This inventory inevitably simplifies the 
data available in the cohorts. For example, 
we summarized time periods over which 
data were collected, meaning that not each 
follow-up point in each cohort is represented. 
Furthermore, we restricted information 
about exposure and health outcome assess-
ment methods to relatively basic questions 
[see Supplemental Material, Annex 1 (http://
dx.doi.org/10.1289/ehp.1103823)]. It is also 
inevitable that the inventory information 
will become out of date quickly. The Web-
based database will be maintained by send-
ing requests for updates to the included and 
newly identified cohorts at approximately 
yearly intervals for as long as resources allow. 
The inventory is meant to give researchers and 
other professionals looking for specific data the 
first overview of relevant cohorts; only direct 
contact with the cohorts can then establish 
the suitability of data for a specific purpose. 
Beyond our overview here, the ENRIECO 
project has made an extensive effort to com-
pare available data and methods across cohorts 
and to develop recommendations for the use 
of existing data and for the collection of data 
in the future. These reports are available on 
request (ENRIECO 2009).
The 37 European birth cohorts described in 
this review fulfilled all our inclusion criteria. We 
also identified other studies that did not strictly 
match our criteria of a birth cohort study or did 
not collect data on the environmental expo-
sures. We may have missed other birth cohorts 
that have not yet been published or are still in 
planning stages. In addition, many important 
birth cohorts outside Europe were not included. 
The Web-based inventory will be open for the 
inclusion of additional birth cohorts for the 
foreseeable future. Overall, we have achieved an 
excellent response from the European cohorts; 
only three potentially eligible cohorts did not 
return questionnaires. Involvement of the 
cohorts in workshops, working groups, and case 
studies was instrumental in these results.
Table 4. Biomarkers of selected environmental exposures measured by European birth cohorts collaborating in ENRIECO.a 
Cohort Metals Persistent organic pollutants Other pesticides
Tobacco 
smoking Other chemicals
ALSPAC As, Cd, Hg, Mn, Pb, Se,b TMS PFCsb — Cotinine —
ArcRisk-Norway As, Cd, Co, Hg, Mb, Mn , Pb Chlordane, DDT/DDE, HCB, PCBs — — Planned
BAMSE — — — Cotinine —
Czech — — — Cotinine PAHs
DNBC — PFCs — — —
Duisburg Cd, Hg, Pb, Se DDT/DDE, HCB,b HCH, PCBs, PCDDs, 
PCDFs, PFCs
— Cotinineb BPA, phthalates
EDEN B, Cd, Mn, Hg, Pb — — Cotinine Phthalates, phenols (including BPA)
ELFE Al,b As,b Cd,b Hg,b Pbb BFRs,b organochlorines,b PFCs,b PCBs,b 
PCDDs,b PCDFsb
Organophosphates,b 
pyrethroidsb
Cotinineb BPA,b phthalatesb
Faroes Hg, Pb, Se BFRs,b chlordane, DDT/DDE, dieldrin/
endrin, heptachlor, HCB, β-HCH, mirex, 
organometallic compounds, PCBs, 
PFCs,b toxaphene
— — BPA,b phthalatesb
FLEHS I Cd, Pb DDT/DDE, dioxin-like compounds, HCB, 
PCBs
— — —
Generation R — Organochlorinesb Organophosphates — BPA, phthalates
GINIplus — — — Cotinine —
HUMIS Hg,b Pbb BFRs, DDT/DDE, HCB, HCH, mirex, 
PCBs, PCDDs, PCDFs, PFCs, toxaphene
— — Phthalates
INMA old Hg, Pb,b TMSb Aldrin/dieldrin/endrin, BFRs, DDT/DDE, 
endosulfan, lindane, methoxychlor, 
mirex, HCB, HCH, PCBs
— Cotinine Phthalates, phenols (including BPA)
INMA new Hg, Pb, TMSb BFRs, DDT/DDE, HCB, HCH, PCBs — Cotinine Phthalates, phenols (including BPA)
INUENDO Cd,b Hg,b Pbb BFRs,b DDT/DDE, HCB,b PCBs, PFCsb — — BPA,b phthalatesb
Kraków Cd, Hg, Pb — — Cotinine Phthalates, PAHs, benzo[a]pyrene-
adducts
LISAplus — — — Cotinine —
LUKAS As, Cd, Hg, Pb, Se BFRs, DDT/DDE, organometallic 
compounds, PCBs, PCDDs, PCDFs, 
polychlorinated naphthalene
— — Phthalatesb
MAS — — — Cotinine —
MoBa Planned BFRs,b DDT/DDE,b PCBsb Organophosphates — BPA, phthalates
NINFEA — — — — —
PCB cohort Hg, Pb DDT/DDE, HCB, HCH, PCBs, PFCsb — — Phthalatesb
PÉLAGIE Hg Aldrin, BFRs, DDT/DDE, dieldrin/endrin, 
heptachlor, HCB, PCBs
Acetochlor, alachlor, 
metolachlor, 
organophosphorus, 
propoxur, triazines
— Phthalates
REPRO_PL Cd, Hg, Pb, Se, Zn, Cu PCBs, PCDDs, PCDFS — Cotinine PAHs (1-hydroxypyrene)
RHEA As, Cd, Hg, Mn, Pb DDT/DDE,b HCB,b PCBs,b PCDDs,b PFCsb — NNAL, 
cotinine
Phthalatesb
Abbreviations: As, arsenic; B, boron; BFRs, brominated flame retardants; BPA, bisphenol A; Cd, cadmium; Co, cobalt; Cu, copper; DDE, dichlorodiphenyldichloroethylene; DDT, dichlo-
rodiphenyltrichloroethane; HCB, hexachlorobenzene; HCH, hexachlorocyclohexane; Hg, mercury; Mb, molybdenum; Mn, manganese; Ni, nickel; NNAL, 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanol; PAHs, polycyclic aromatic hydrocarbons; Pb, lead; PCBs, polychlorinated biphenyls; PCDDs, polychlorinated dibenzo-p-dioxins; PCDFs, polychlorinated dibenzo 
furans; PFCs, perfluorinated compounds; Se, selenium; Tl, thallium; TMS, total metals spectrum; Zn, zinc. See Table 1 for full names and locations of cohorts.
aIncludes all exposures biomarkers measured as part of the exposure topics included the inventory questionnaire [see Supplemental Material, Annex 1 (http://dx.doi.org/10.1289/
ehp.1103823)]. Details of each assessment (method, time period, number of subjects) are available at www.birthcohortsenrieco.net (ENRIECO 2011). bMeasurements are planned or 
ongoing but not completed.Vrijheid et al.
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Future collaboration. The 350,000 
mother–  child pairs covered by European birth 
cohorts form an impressive number, but of 
course this is only a small percentage of all 
births in Europe [(> 5 million births annually 
in 25 EU countries (Eurostat 2011)]. For the 
investigation of any specific exposure–outcome 
relationship, the number of available subjects 
will be much smaller than the total number of 
children followed by the cohorts. The cohorts 
are in very different stages of follow-up and 
thus have not all reached the ages at which 
some outcomes, for example, asthma or 
puberty onset, can be assessed. Moreover, not 
all exposure and outcome topics included in 
ENRIECO are immediately suitable for com-
bined analyses of individual data. However, 
there are many reasons why continued and 
tightly coordinated collaboration between 
existing cohorts is desirable (Kogevinas et al. 
2004; Willett et al. 2007): a) combined analy-
ses of cohort data to improve statistical power 
and reduce publication bias; b) improved con-
trast and diversity in exposure and outcome; 
c) faster response to concerns about new envi-
ronmental exposures; d) facilitation of rep-
lication and comparison studies in different 
settings; e) facilitation of linkage to large-scale, 
routinely collected environmental and health 
data; and f) widening expertise to improve 
methodological approaches, including proto-
cols of biological and environmental sample 
collection and analysis.
In conclusion, the impressive resource of 
existing data in birth cohorts should form the 
basis for a long-term infrastructure that brings 
together birth cohort research on early-life 
environmental contaminant exposure and child 
health, with the ultimate aim to improve causal 
inference in this field. Further expansion to 
countries outside Europe should be one impor-
tant aim for the future. This will be possible 
only with continued support for coordination.
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